Format

Send to

Choose Destination
Leukemia. 2016 May;30(5):1220-1225. doi: 10.1038/leu.2015.292. Epub 2015 Oct 21.

Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivo.

Author information

1
Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Saxony-Anhalt, Germany.
2
Department of Internal Medicine III, University of Ulm, Ulm, Baden-Württemberg, Germany.
3
Department of Pediatric Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
4
Department of Cardiology and Angiology, Center of Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Saxony-Anhalt, Germany.
5
Tumor Initiation and Maintenance, Sanford Burnham Medical Research Institute, La Jolla, CA, USA.
6
Human Oncology and Pathogenesis Program and Department of Pediatrics, Memorial Sloan-Kettering Cancer Institute, New York, NY, USA.
#
Contributed equally
PMID:
26487272
PMCID:
PMC4840097
DOI:
10.1038/leu.2015.292
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center